Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $66,841.92 +0.37%
Ethereum $2,050.03 -0.10%
BNB $588.83 +0.54%
Optimism $0.11 +2.20%
Arbitrum $0.09 -0.56%
Solana $80.20 +1.30%
Polygon $0.22 +2.77%
Cosmos $1.69 -0.84%
Avalanche $8.89 +1.22%

Bitcoin $66,841.92 +0.37%
Ethereum $2,050.03 -0.10%
BNB $588.83 +0.54%
Optimism $0.11 +2.20%
Arbitrum $0.09 -0.56%
Solana $80.20 +1.30%
Polygon $0.22 +2.77%
Cosmos $1.69 -0.84%
Avalanche $8.89 +1.22%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B